- Joined
- Dec 5, 2023
- Messages
- 1
Interested in a cell-derived regenerative medicine product? The goal of these IBD clinical trials is to see if the investigational product, ExoFlo™, can help reduce inflammation in adults with CD or UC. ExoFlo™ is a safe cell-derived therapy with no described side effects.
You may qualify if you:
• Are 18 to 75 years of age.
• Have been diagnosed with CD or UC for at least 6 months.
• Have failed, lost response, or are intolerant to a monoclonal antibody.
For more information on these IBD clinical trials, scan the QR code or visit ibdclinicaltrials.com.
You may qualify if you:
• Are 18 to 75 years of age.
• Have been diagnosed with CD or UC for at least 6 months.
• Have failed, lost response, or are intolerant to a monoclonal antibody.
For more information on these IBD clinical trials, scan the QR code or visit ibdclinicaltrials.com.
